MYC targets and E2F targets-related pathways were also enriched in L-SCLC, while neuroactive ligand-receptor interaction and KRAS signaling pathways were enriched in LCC/LCNEC (Fig. 2D). Here, KRAS is linked to large cell neuroendocrine carcinoma.